Telomerase enzyme inhibition (TEI) and cytolytic therapy in the management of androgen independent osseous metastatic prostate cancer

Yingming Li, Bahaa S. Malaeb, Zhong Ze Li, Melissa G. Thompson, Zhi Chen, David R. Corey, Jer Tsong Hsieh, Jerry W. Shay, Kenneth S. Koeneman

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Telomerase enzyme inhibition (TEI) and cytolytic therapy in the management of androgen independent osseous metastatic prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences